Clinical Trial Results: Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating once-daily semaglutide tablets in East Asian individuals who are overweight or obese; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight and Obesity | Phase 3 | Status: COMPLETED | Results posted: 2026-08-14